Skip to main content
. 2017 Nov 13;6(12):2867–2875. doi: 10.1002/cam4.1244

Figure 3.

Figure 3

The disease‐specific survival and disease‐overall survival of ER‐positive groups of PLC patients and IDC patients. Kaplan–Meier test for disease‐specific survival (χ 2 = 1.929, = 0.1521, Fig. 3A) and disease‐overall survival (χ 2 = 0.741, = 0.3674, Fig. 3B) to compare ER‐positive groups of PLC patients and IDC patients.